drugset / Trial / NCT01107054
A Study to Investigate the Effects of PF00610335 on the QT/QTC Interval in Healthy Volunteers
RandomizedCrossoverDouble-blindTreatment
Summary
A study to determine the cardiovascular effects of PF00610335 in healthy volunteers.
Timeline
- Start
- 2010-06
- Primary completion
- 2010-09
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Moxifloxacin | Small molecule | 400 mg | Oral |
| Subject | PF-00610355 | Small molecule | 450 ug | Inhaled |
| Subject | PF-00610355 | Small molecule | 1200 ug | Inhaled |